The Topical Novel Formulations of Interferon α-2в Effectively Inhibit HSV-1 Keratitis in the Rabbit Eye Model and HSV-2 Genital Herpes in Mice.

Herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2) are widespread human pathogens that establish chronic latent infections leading to recurrent episodes. Current treatments are limited, necessitating the development of novel antiviral strategies. This study aimed to assess the antiviral efficacy of novel topical formulations containing interferon alpha-2b (IFN α-2b) against HSV-1 and HSV-2.

A Hydrogen-Bromate Flow Battery as a Rechargeable Chemical Power Source.

The hydrogen-bromate flow battery represents one of the promising variants for hybrid power sources. Its membrane-electrode assembly (MEA) combines a hydrogen gas diffusion anode and a porous flow-through cathode where bromate reduction takes place from its acidized aqueous solution: BrO3− + 6 H+ + 6 e− = Br− + 3 H2O (*). The process of electric current generation occurs on the basis of the overall reaction: 3 H2 + BrO3− = Br− + 3 H2O (**), which has been studied in previous publications.

[Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models].

Introduction: The variability of SARS-CoV-2 appeared to be higher than expected, the emergence of new variants raises concerns. The aim of the work was to compare the pathogenicity of the Wuhan and BA.1.

Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human Gene Mediated by Intranasal Administration of AAV-hACE2.

One of the most important steps in the development of drugs and vaccines against a new coronavirus infection is their testing on a relevant animal model. The laboratory mouse, with well-studied immunology, is the preferred mammalian model in experimental medicine. However, mice are not susceptible to infection with SARS-CoV-2 due to the lack of human angiotensin-converting enzyme (hACE2), which is the cell receptor of SARS-CoV-2 and necessary for the entry of the virus into the cell.

[Generation of SARS-CoV-2 Mouse Model by Transient Expression of the Human ACE2 Gene Mediated by Intranasal Administration of AAV-hACE2].

One of the most important steps in the development of drugs and vaccines against a new coronavirus infection is their testing on a relevant animal model. The laboratory mouse, with well-studied immunology, is the preferred mammalian model in experimental medicine. However, mice are not susceptible to infection with SARS-CoV-2 due to the lack of human angiotensin-converting enzyme (hACE2), which is the cell receptor of SARS-CoV-2 and necessary for the entry of the virus into the cell.